Detailed explanation of the basic structure and function of the buried cardioverter defibrillator (ICD)

1. Basic Structure and Function of an Implantable Cardioverter Defibrillator (ICD)

An ICD is a small device implanted in the chest that monitors heart rhythms and delivers electrical shocks to restore normal rhythm when dangerous arrhythmias occur. It consists of two main components: a pulse generator and one or more electrode leads. The pulse generator houses the battery, sensing and pacing circuits, and a capacitor. The battery provides power, while the capacitor stores and releases energy for shocks. The sensing and pacing circuits monitor the heart’s electrical activity, detect abnormal rhythms such as ventricular tachycardia (VT) and ventricular fibrillation (VF), and deliver pacing pulses when necessary.

The early versions of ICDs used epicardial electrodes, which required open-heart surgery for placement. Over time, this evolved into subcutaneous electrodes, and now most ICDs use transvenous endocardial leads, which are inserted through veins and positioned directly inside the heart. This method has greatly simplified the implantation process. The electrode lead transmits signals from the heart to the pulse generator and also delivers pacing or shock therapy to the heart. Depending on the electrode configuration, shocks can be delivered via the transvenous lead and the pulse generator housing, or solely by the endocardial lead itself.

The primary function of an ICD is to recognize and treat both tachyarrhythmias (fast heartbeats) and bradycardias (slow heartbeats). Its approach to managing bradycardia is similar to that of a pacemaker. However, this section will focus on how ICDs identify and manage tachyarrhythmias.

1.1 Recognition of Rapid Arrhythmias

ICDs use heart rate and the duration of the arrhythmia as the basic criteria for identifying tachyarrhythmias. These criteria include initial recognition and re-identification. Initial recognition is used to detect the start of an arrhythmia episode, while re-identification confirms whether the arrhythmia persists after attempted treatment. VT and VF are typically differentiated based on frequency, though specific criteria may vary between manufacturers.

For example, CPI devices may set recognition criteria using beats per minute and seconds, whereas Medtronic devices often use cycle length (in milliseconds) and the number of consecutive cycles. Let's take an example: if the VT recognition criterion is set at 150 beats per minute and requires a 10-second duration, the ICD will initiate treatment. In the case of a CPI Ventak PRx III model, the frequency is set to 150 bpm and the duration to 6 seconds, since the timing starts once the frequency threshold is met. The ICD continuously monitors the heart rate by comparing each beat's circumference to the set threshold. If 8 out of 10 consecutive beats meet the criteria, the ICD confirms the arrhythmia and begins calculating the duration.

If the frequency is 150 bpm (400 ms per beat), and the ICD detects 10 consecutive beats with a circumference equal to or shorter than 400 ms, it will trigger treatment. Before the duration calculation begins, the arrhythmia must have lasted at least 10 beats. With the 150 bpm threshold, 10 beats would last about 4 seconds, so the duration is set to 6 seconds, making the total duration 10 seconds. If the ICD continues to detect 6 out of 10 beats meeting the criteria during the 6-second window, treatment will begin. Otherwise, the ICD must re-detect 8 out of 10 beats before restarting the duration timer.

In contrast, Medtronic’s Jewel series might require a frequency setting of 400 ms and a duration of 24 beats (equivalent to 10 seconds). If 24 consecutive beats meet the criteria, treatment is initiated. Here, the timing starts simultaneously with the frequency detection, unlike in CPI models. Similar principles apply to ventricular fibrillation (VF), where the ICD uses heart rate and duration as diagnostic criteria. Additional features like sudden onset and stability help differentiate VT from other arrhythmias such as sinus tachycardia or atrial fibrillation.

Sudden onset refers to how quickly the arrhythmia develops compared to normal sinus rhythm, usually expressed as a percentage. VT typically appears abruptly, while sinus tachycardia develops gradually. Stability measures the regularity of the rhythm during tachycardia, expressed in milliseconds. VT is usually regular, while atrial fibrillation is irregular. Some ICDs also use QRS complex width to distinguish between VT and supraventricular tachycardia (SVT).

1.2 Treatment of Rapid Arrhythmias

There are two primary methods for treating rapid arrhythmias: electrical shock and anti-tachycardia pacing (ATP).

(1) Electrical Shock: Most modern ICDs deliver shocks ranging from 0.1 to 34 joules, with some models capable of up to 42 J. They can deliver multiple shocks in sequence, typically up to six. Both VT and VF can be treated with this method.

(2) ATP: There are two main types of ATP: short-cycle rapid pacing and ramp pacing. Short-cycle rapid pacing involves pacing at a rate slightly faster than the tachycardia, usually around 75–80% of the tachycardia cycle length. This method has a high success rate in terminating the arrhythmia. However, too few or too many pulses may be ineffective or even worsen the condition.

Ramp pacing involves gradually decreasing the pacing interval over time. This method can be more effective but carries a higher risk of accelerating the arrhythmia, especially if too many pulses are delivered.

While VF is typically treated with electric shock, VT can be managed with either ATP or shock. Lower-energy shocks are often sufficient for VT, and ATP programs can be customized to match the patient’s rhythm. If ATP fails, low-energy shocks may be used first, followed by high-energy shocks if needed.

Additionally, ICDs store detailed information about detected arrhythmias, including heart rate, duration, interbeat intervals, treatment times, and responses. This data helps physicians fine-tune the device settings and improve future care. Many ICDs also support electrophysiological testing, allowing doctors to induce arrhythmias and evaluate the effectiveness of the treatment protocols.

Air/Cabin Filter

Air/Cabin Filter

Air Cabin Filter,Car Air Cabin Filter,Automobile Air Cabin Filter,Auto Air Cabin Filter

Zhoushan Shenying Filter Manufacture Co., Ltd. , https://www.renkenfilter.com

Posted on